Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
HHS secretary panel on regulatory reform: Inaugural meeting Jan. 7 at Providence Hospital in Washington, D.C. will precede a series of regional public hearings to solicit comments on proposed regulatory changes concerning medical product development and other issues. A list of committee members, including over 20 health industry officials, will be made available the week of Dec. 24...
You may also be interested in...
Japan Reimbursement Guidelines Allow Semiannual Review For C1 Devices
Redetermination of reimbursement for "next-generation" (C1 Category) medical devices by Japan's Ministry of Health, Labour and Welfare on a six-month basis is expected to begin April 1, under a newly revised policy in that country
Japan Reimbursement Guidelines Allow Semiannual Review For C1 Devices
Redetermination of reimbursement for "next-generation" (C1 Category) medical devices by Japan's Ministry of Health, Labour and Welfare on a six-month basis is expected to begin April 1, under a newly revised policy in that country
FDA Inspections, Bar-Coding Rank Among Agency’s Regulatory Reform Items
FDA is highlighting the inspection process as one area in need of improvement as part of overall HHS regulatory reform efforts